A major aspect of the 4th Annual Amoeba Summit, hosted by the Jordan Smelski Foundation, was a strong and necessary devotion to more drug research.

I had the chance to speak with the Director, Center for Tropical & Emerging Global Diseases at the University of Georgia, Dennis Kyle, PhD.

Dr Kyle discussed the research being done, the challenges with drug discovery for Naegleria fowleri and the collaborations among researchers.

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | Stitcher | RSS

 


Related:

Naegleria fowleri: Lab diagnosis with Shiela Black, MHM, BSMT(ASCP)

Naegleria fowleri: The Sebastian DeLeon case with Dr. Humberto Liriano

Naegleria fowleri: 4th Annual Amoeba Summit with Dr Jennifer Cope

Naegleria fowleri: Study on death estimates, treatment success and the northward expansion of infections

Naegleria fowleri: An interview with Dr Jennifer Cope

Naegleria fowleri and the Jordan Smelski Foundation for Amoeba Awareness

Naegleria fowleri, Acanthamoeba species and Balamuthia mandrillaris: Uncommon, accidental, yet high consequence

 

Subscribe to Outbreak News TV

Online Press Release Service, White Label Press Release distribution, Press Release Distribution Service, Press Release.

Balamuthia, neti pots and a unique case report

Balamuthia mandrillaris: Koral Reef’s story